Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Placebo-subtracted mean weight loss up to 8.4% at Day 36 19-day observed half-life supports once-monthly dosing as monotherapy and potential first-in-category monthly GLP-1 + Amylin combination ...

Prime Minister unveiled plans to boost UK’s high-performance compute capacity 20-fold, along with funding to bolster skills.

After stumbling out of the starting gate in Big Tech’s pivotal race to create artificial intelligence, Apple will try to ...

Blue Owl Capital's high permanent capital base and strong fee growth should support consistent earnings across market cycles.

Wall Street surged as the S&P 500 surpassed 6,000. Discover top tech gainers like ON & MU, key losers, and ETF performance in this week's market wrap-up!

Apple has an opportunity to deliver a WWDC that would encourage developers to invest more of their time in the ecosystem.